Canadian non-profit coalition of healthcare professionals and advocates advancing access to psilocybin-assisted psychotherapy. It trains clinicians, supports patients seeking access and advocates for regulatory reform in Canada.

Biotech company developing psilocybin therapy (COMP360) for treatment-resistant depression. Advancing clinical trials toward regulatory approval.

Spearheading research of psychedelics

Pioneering force in integrating spiritual care within Australia’s health sector

Strategic Leadership for Global Psychedelic Safety

Advancing research into Psychedelics

Biggest non-profit driving psychedelic research & advocacy

Research and advocacy for the responsible integration of emergent practices among clinicians, academia and practitioners.